New Aspects of an Old Drug – Diclofenac Targets MYC and Glucose Metabolism in Tumor Cells

• Eva Gottfried,

  Affiliations Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany, Regensburg Centre for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany

  ⨯
• Sven A. Lang,

  Affiliation Department of Surgery, University of Regensburg, Regensburg, Germany

  ⨯
• Kathrin Renner,

  Affiliations Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany, Regensburg Centre for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany

  ⨯
• Anja Bosserhoff,

  Affiliation Institute of Pathology, University of Regensburg, Regensburg, Germany

  ⨯
• Wolfram Gronwald,

  Affiliation Institute of Functional Genomics, University of Regensburg, Regensburg, Germany

  ⨯
• Michael Rehli,

  Affiliations Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany, Regensburg Centre for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany

  ⨯
• Sabine Einhell,

  Affiliation Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany

  ⨯
• Isabel Gedig,

  Affiliation Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany

  ⨯
• Katrin Singer,

  Affiliation Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany

  ⨯
• Anton Seilbeck,

  Affiliation Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany

  ⨯
• Andreas Mackensen,

  Affiliation Department of Internal Medicine 5, Hematology/Oncology, University of Erlangen, Erlangen, Germany

  ⨯
• Oliver Grauer,

  Affiliations Department of Neurology, University of Muenster, Muenster, Germany, Department of Neurology, University of Regensburg, Regensburg, Germany

  ⨯
• Peter Hau,

  Affiliations Department of Neurology, University of Regensburg, Regensburg, Germany, Wilhelm Sander NeuroOncology Unit, University of Regensburg, Regensburg, Germany

  ⨯
• Katja Dettmer,

  Affiliation Institute of Functional Genomics, University of Regensburg, Regensburg, Germany

  ⨯
• Reinhard Andreesen,

  Affiliations Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany, Regensburg Centre for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany

  ⨯
• Peter J. Oefner,

  Affiliation Institute of Functional Genomics, University of Regensburg, Regensburg, Germany

  ⨯
•  [ ... ],
• Marina Kreutz

  * E-mail: marina.kreutz@ukr.de

  Affiliations Department of Hematology and Oncology, University of Regensburg, Regensburg, Germany, Regensburg Centre for Interventional Immunology (RCI), University of Regensburg, Regensburg, Germany

  ⨯
• [ view all ]
• [ view less ]